Lallemand: Bio-Ingredients president sheds light on Evolva acquisition
23 Jan 2024 | Lallemand
Lallemand Bio-Ingredients president and general manager Lars Asferg unravels the potential in the company’s recent acquisition of Swiss biotechnology firm Evolva. Asferg discusses how Evolva’s precision fermentation tech could boost Lallemand’s health and flavor and fragrance businesses. He also outlines the business unit’s key focuses for 2024.
More videos